Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Feb;13(2):180–183. doi: 10.1128/aac.13.2.180

Clinical Pharmacology of Mezlocillin

Brian F Issell 1, Gerald P Bodey 1, Susanne Weaver 1
PMCID: PMC352210  PMID: 646340

Abstract

Mezlocillin is a new broad-spectrum semisynthetic penicillin that has shown encouraging in vitro activity against the infecting organisms most likely to cause mortality and morbidity in cancer patients receiving chemotherapy. The serum clearances and urine recoveries of mezlocillin, ampicillin, and carbenicillin were compared after the intravenous administration of single 3-g doses. The peak mean serum concentrations of mezlocillin and carbenicillin were 269 and 278 μg/ml, respectively, whereas the peak ampicillin level was lower at 167 μg/ml. The terminal half-life of mezlocillin, 66 min, was not significantly different from those of ampicillin and carbencillin (63 and 77 min, respectively). Recoveries of mezlocillin, ampicillin, and carbenicillin from urine over 6-h periods after drug dosage were 45, 61, and 80%, respectively. A further study in 11 cancer patients examined serum maintenance levels of mezlocillin when 3-g doses were given intravenously every 4 h for at least 7 consecutive days. After 3 days of therapy, the mean serum concentrations were maintained above 50 μg/ml. Although therapeutic efficacy was not an objective of this study, all of three documented bacterial infections were cured, and no serious toxicity was encountered.

Full text

PDF
180

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin D. S., Levine B. B., McCluskey R. T., Gallo G. R. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med. 1968 Dec 5;279(23):1245–1252. doi: 10.1056/NEJM196812052792302. [DOI] [PubMed] [Google Scholar]
  2. Bergan T., Oydvin B. Cross-over study of penicillin pharmacokinetics after intravenous infusions. Chemotherapy. 1974;20(5):263–279. doi: 10.1159/000221816. [DOI] [PubMed] [Google Scholar]
  3. Bloomfield C. D., Kennedy B. J. Cephalothin, carbenicillin, and gentamicin combination therapy for febrile patients with acute non-lymphocytic leukemia. Cancer. 1974 Aug;34(2):431–437. doi: 10.1002/1097-0142(197408)34:2<431::aid-cncr2820340229>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  4. Bodey G. P. Infections in cancer patients. Cancer Treat Rev. 1975 Jun;2(2):89–128. doi: 10.1016/s0305-7372(75)80005-3. [DOI] [PubMed] [Google Scholar]
  5. Bodey G. P., Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin. Antimicrob Agents Chemother. 1977 Jan;11(1):74–79. doi: 10.1128/aac.11.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brauninger G. E., Remington J. S. Nephropathy associated with methicillin therapy. JAMA. 1968 Jan 8;203(2):103–105. [PubMed] [Google Scholar]
  7. FEIGIN R. D., FIASCONE A. HEMATURIA AND PROTEINURIA ASSOCIATED WITH METHICILLIN ADMINISTRATION. N Engl J Med. 1965 Apr 29;272:903–904. doi: 10.1056/NEJM196504292721708. [DOI] [PubMed] [Google Scholar]
  8. GRATTAN W. A. HEMATURIA AND AZOTEMIA ASSOCIATED WITH ADMINISTRATION OF METHICILLIN. J Pediatr. 1964 Feb;64:285–287. [PubMed] [Google Scholar]
  9. Kunin C. M. Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clin Pharmacol Ther. 1966 Mar-Apr;7(2):166–179. doi: 10.1002/cpt196672166. [DOI] [PubMed] [Google Scholar]
  10. Line D. E., Adler S., Fraley D. S., Burns F. J. Massive pseudoproteinuria caused by nafcillin. JAMA. 1976 Mar 22;235(12):1259–1259. [PubMed] [Google Scholar]
  11. Schimpff S. C., Landesman S., Hahn D. M., Standiford H. C., Fortner C. L., Young V. M., Wiernik P. H. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. Antimicrob Agents Chemother. 1976 Nov;10(5):837–844. doi: 10.1128/aac.10.5.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schrier R. W., Bulger R. J., VanArsdel P. P., Jr Nephropathy associated with penicillin and homologues. Ann Intern Med. 1966 Jan;64(1):116–127. doi: 10.7326/0003-4819-64-1-116. [DOI] [PubMed] [Google Scholar]
  13. Sutter V. L., Finegold S. M. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother. 1976 Oct;10(4):736–752. doi: 10.1128/aac.10.4.736. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES